Kardigan, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kardigan, Inc. (KARD) holds an ST Score of 65.1 out of 100 (B), with its strongest factor being Sentiment (A+) and its weakest Momentum (D). Analysts rate KARD Buy across 1 ratings with a $38.50 average price target (+1.3% vs the current $16.64).
- Strongest
- SentimentA+
- Weakest
- MomentumD
All factor grades
- SentimentA+
- ValuationA
- ForecastA
- Financial StrengthB+
- ProfitabilityC+
- GrowthC+
- MomentumD
Contact
KARD stock: frequently asked questions
What is KARD's ST Score?
Kardigan, Inc. (KARD) has an ST Score of 65.1 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KARD a buy, sell, or hold?
Wall Street's consensus rating on KARD is Buy based on 1 analyst ratings. Our own ST Score grades it B (65.1/100). This is data, not investment advice — always do your own research.
What is KARD's valuation grade?
Kardigan, Inc. (KARD) earns a valuation grade of A, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KARD's growth grade?
Kardigan, Inc. (KARD) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KARD's profitability grade?
Kardigan, Inc. (KARD) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KARD's financial strength grade?
Kardigan, Inc. (KARD) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KARD?
The average analyst price target for Kardigan, Inc. (KARD) is $38.50 from 1 analysts, which is +1.3% versus the recent price of $16.64.